Results 41 to 50 of about 88,700 (323)

Constrained Best Linear Unbiased Estimation

open access: yes, 2017
The least squares (LS) estimator and the best linear unbiased estimator (BLUE) are two well-studied approaches for the estimation of a deterministic but unknown parameter vector. In many applications it is known that the parameter vector fulfills some constraints, e.g., linear constraints.
Lang, Oliver   +2 more
openaire   +2 more sources

All about the ⊥ with its applications in the linear statistical models

open access: yesOpen Mathematics, 2015
For an n x m real matrix A the matrix A⊥ is defined as a matrix spanning the orthocomplement of the column space of A, when the orthogonality is defined with respect to the standard inner product ⟨x, y⟩ = x'y.
Markiewicz Augustyn, Puntanen Simo
doaj   +1 more source

Design-based composite estimation of small proportions in small domains

open access: yesNonlinear Analysis, 2023
Traditional direct estimation methods are inefficient for domains of a survey population with small sample sizes. To estimate the domain proportions, we combine the direct estimators and the regression-synthetic estimators based on domain-level ...
Andrius Čiginas
doaj   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

open access: yesMolecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad   +12 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

A Blended Sea Ice Concentration Product from AMSR2 and VIIRS

open access: yesRemote Sensing, 2021
An effective blended Sea-Ice Concentration (SIC) product has been developed that utilizes ice concentrations from passive microwave and visible/infrared satellite instruments, specifically the Advanced Microwave Scanning Radiometer-2 (AMSR2) and the ...
Richard Dworak   +3 more
doaj   +1 more source

Best Linear Unbiased Estimators for Repeated Surveys

open access: yesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1980
Summary Recent work on the problem of obtaining best linear unbiased estimators from a sample survey which is repeated on several occasions has centred on the effects of extending the model assumptions to allow for stochastic variation in the parameters being estimated.
openaire   +2 more sources

Pathogenic Neurofibromatosis type 1 gene variants in tumors of non‐NF1 patients and role of R1276

open access: yesFEBS Open Bio, EarlyView.
Somatic variants of the neurofibromatosis type 1 (NF1) gene occur across neoplasms without clinical manifestation of the disease NF1. We identified emerging somatic pathogenic NF1 variants and hotspots, for example, at the arginine finger 1276. Those missense variants provide fundamental information about neurofibromin's role in cancer.
Mareike Selig   +7 more
wiley   +1 more source

Mean squared error of empirical predictor

open access: yes, 2004
The term ``empirical predictor'' refers to a two-stage predictor of a linear combination of fixed and random effects. In the first stage, a predictor is obtained but it involves unknown parameters; thus, in the second stage, the unknown parameters are ...
Das, Kalyan   +2 more
core   +2 more sources

Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Clinical trials for Huntington's disease (HD) enrolling persons before clinical motor diagnosis (CMD) lack validated biomarkers. This study aimed to conduct an unbiased discovery analysis and a targeted examination of proteomic biomarkers scrutinized by clinical validation. Methods Cerebrospinal fluid was obtained from PREDICT‐HD and
Daniel Chelsky   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy